Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has announced a new application for the quotation of securities, specifically for 149,625,180 fully paid ordinary shares under the ASX code RAD, as detailed in their latest financial documents dated August 23, 2024. Investors may show keen interest as the company prepares for its new securities to be quoted on the ASX, signaling potential growth and investment opportunities.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.